Lemonade
LMND
$49.22
-2.63%
Lemonade, Inc. is a financial services company that leverages artificial intelligence and digital platforms to offer renters, homeowners, pet, and car insurance, primarily in the United States and Europe. As a disruptor in the property and casualty insurance industry, it differentiates itself through a customer-centric, tech-enabled model that promises transparency and social impact, appealing to a younger, digitally native demographic. The current investor narrative centers on Lemonade's accelerating revenue growth and improving loss ratios, with management guiding to adjusted EBITDA breakeven by Q4 2026, a milestone that could validate its AI-driven underwriting and claims processing. However, the stock has been volatile, with recent concerns about valuation, a Morgan Stanley downgrade, and a softer auto insurance market creating debate about whether the growth story justifies the premium multiple.…
LMND
Lemonade
$49.22
Related headlines
Investment Opinion: Should I buy LMND Today?
Based on the analysis, I rate LMND as a Hold. The company's accelerating revenue growth (55% YoY) and improving margins are compelling, but the valuation at 6.93x PS leaves little room for error. The analyst consensus is Hold with an average target of $59.22, implying 10.96% upside, which is modest given the risks. The thesis is that Lemonade is a high-growth disruptor with a clear path to profitability, but the current price already reflects much of the optimism.
Sign up to view all
LMND 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Lemonade's growth and margin improvement are impressive, but the valuation is stretched, and the stock has underperformed the market significantly. The key factor is whether the company can sustain its growth while achieving profitability. If revenue growth continues above 50% and margins keep improving, the stock could re-rate higher. However, any sign of deceleration or missed profitability targets would likely lead to a sharp sell-off. I would upgrade to bullish if the stock price drops below $46 while fundamentals remain intact, or if the company beats on profitability guidance. I would downgrade to bearish if revenue growth falls below 30% or if the company delays its breakeven timeline.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lemonade's 12-month outlook, with a consensus price target around $59.22 and implied upside of +20.3% versus the current price.
Average Target
$59.22
0 analysts
Implied Upside
+20.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$37 - $92
Analyst target range
Analyst coverage is moderate, with 9 analysts providing ratings, and the consensus recommendation is 'Hold' with a mean rating of 2.91 (where 1 is Strong Buy and 5 is Sell). The average target price is $59.22, implying an upside of 10.96% from the current price of $53.37. The distribution includes 3 Buy ratings, 4 Hold ratings, and 2 Sell/Underperform ratings, indicating a cautious but not overly bearish sentiment. The target price range spans from $37.00 to $92.00, with the low target suggesting a potential 30.7% downside, while the high target implies a 72.4% upside. The wide spread reflects high uncertainty about Lemonade's path to profitability and its ability to sustain growth in a competitive market. Recent rating actions show a mix of upgrades and downgrades, with Morgan Stanley downgrading from Overweight to Equal Weight in July 2026, while Truist Securities maintains a Buy, indicating divergent views on the stock's risk-reward profile.
Bulls vs Bears: LMND Investment Factors
Lemonade presents a classic high-growth, high-risk investment. The bull case is anchored on accelerating revenue growth (55% YoY), dramatic margin improvement (gross margin up to 43.1%), and a clear path to EBITDA breakeven by Q4 2026. The bear case centers on a rich valuation (6.93x PS vs. 1.5x industry), persistent losses, and significant underperformance relative to the market. Currently, the evidence slightly favors the bull case given the improving fundamentals, but the valuation leaves no margin for error. The key tension is whether Lemonade can sustain its growth trajectory while achieving profitability—if it does, the stock is undervalued; if growth decelerates, the premium multiple will compress. Investors should monitor quarterly revenue growth and margin trends closely.
Bullish
- Revenue growth accelerating to 55%: Q1 2026 revenue of $234.4 million grew 55.03% YoY, up from 51% in Q4 2025 and 27% in Q3 2025, showing clear acceleration. This outpaces the industry's 10-15% growth, justifying a premium valuation.
- Gross margin improved to 43.1%: Gross margin jumped to 43.13% in Q1 2026 from 26.26% a year ago, reflecting better underwriting and cost efficiencies. This trend is critical for reaching profitability.
- Net loss narrowing significantly: Net loss margin improved to -15.27% in Q1 2026 from -41.27% in Q1 2025, with net loss of $35.8 million. The company is on track for adjusted EBITDA breakeven by Q4 2026.
- Positive free cash flow on TTM basis: Trailing twelve-month free cash flow is positive at $19.5 million, a key milestone for a growth company. This reduces reliance on external financing and supports the path to profitability.
Bearish
- Valuation at 362% premium to industry: PS ratio of 6.93x is 362% above the industry average of 1.5x, leaving little room for error. If growth decelerates, the multiple could compress sharply.
- Stock underperforming market badly: Over the past year, LMND fell 4.87% while the S&P 500 gained 20.48%, resulting in relative underperformance of -25.35%. The stock is in a clear downtrend.
- High volatility with beta of 1.86: Beta of 1.86 means the stock is 86% more volatile than the market, amplifying downside in sell-offs. Recent 1-month drop of -15.85% illustrates this risk.
- Analyst consensus is Hold, not Buy: With a mean rating of 2.91 (Hold) and only 3 Buy ratings out of 9, analysts are cautious. The average target of $59.22 implies just 10.96% upside, limiting near-term reward.
LMND Technical Analysis
Lemonade's stock is in a clear downtrend over the past year, with a 1-year price change of -4.87%, while the S&P 500 gained 20.48% over the same period, resulting in a relative strength of -25.35%. The current price of $53.37 sits at 53.4% of the 52-week range (low $46.16, high $99.90), indicating the stock has fallen significantly from its highs but remains above its low. This positioning suggests a stock that has lost momentum but is not yet at extreme oversold levels, potentially offering a value opportunity if fundamentals improve, but also carrying the risk of further downside if the downtrend persists.
Beta
1.87
1.87x market volatility
Max Drawdown
-50.9%
Largest decline past year
52-Week Range
$46-$100
Price range past year
Annual Return
-6.9%
Cumulative gain past year
| Period | LMND Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | -1.4% |
| 3m | -13.9% | +3.3% |
| 6m | -10.8% | +15.1% |
| 1y | -6.9% | +17.2% |
| ytd | -35.2% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LMND Fundamental Analysis
Lemonade's revenue growth is accelerating, with Q1 2026 revenue of $234.4 million, up 55.03% year-over-year, compared to 51% growth in Q4 2025 and 27% in Q3 2025. The company's gross margin improved to 43.13% in Q1 2026 from 26.26% in Q1 2025, reflecting better underwriting and cost efficiencies. Despite this, the company remains unprofitable, with a net loss of $35.8 million in Q1 2026, though the net loss margin narrowed to -15.27% from -41.27% a year earlier. The balance sheet shows a debt-to-equity ratio of 0.34, indicating moderate leverage, and the company generated positive free cash flow of $19.5 million on a trailing twelve-month basis, though Q1 2026 saw a slight negative FCF of -$4.1 million. With $386.5 million in cash and a current ratio of 1.52, Lemonade has sufficient liquidity to fund its operations, but its reliance on external financing is evident from the $26.2 million raised in financing activities in Q1 2026.
Quarterly Revenue
$234400000.0B
2026-03
Revenue YoY Growth
+55.0%
YoY Comparison
Gross Margin
43.1%
Latest Quarter
Free Cash Flow
$19500001.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LMND Overvalued?
Given Lemonade's negative net income, the price-to-sales (PS) ratio is the most appropriate valuation metric, and at 6.93x trailing sales, it reflects the market's high growth expectations. The forward PS ratio, based on estimated 2026 revenue of $2.616 billion, is approximately 1.96x, implying a significant discount to the trailing multiple and suggesting the market expects substantial revenue growth. Compared to the industry average PS ratio of 1.5x (from valuation data), Lemonade trades at a 362% premium, which is justified by its superior growth rate of 55% versus the industry's 10-15%, but leaves little room for error. Historically, Lemonade's PS ratio has ranged from 6.1x to 115.6x over the past five years, with the current 6.93x near the lower end of that range, indicating that the stock is relatively cheap compared to its own history, though this could reflect deteriorating growth prospects or a more mature business stage.
PE
-30.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-33.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. Lemonade remains unprofitable, with a net loss of $35.8 million in Q1 2026, though the loss margin narrowed to -15.27%. The company's debt-to-equity ratio is 0.34, indicating moderate leverage, but it still relies on external financing, as evidenced by $26.2 million raised in financing activities in Q1 2026. Free cash flow was slightly negative at -$4.1 million in Q1, though positive on a TTM basis. The company's cash position of $386.5 million provides a cushion, but continued losses could deplete it if growth slows. Revenue concentration in the P&C insurance market, particularly in the US and Europe, exposes it to regulatory and competitive pressures.